HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Radiology17 papers

Myelodysplastic neoplasm of childhood

Last edited: 4/15/2026

Overview

Myelodysplastic neoplasms (MDS) in childhood are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and a risk of progression to acute myeloid leukemia (AML). 1 does not directly address childhood MDS but highlights the importance of specialized pediatric care, including interventional radiology, in managing complex pediatric hematological conditions.

Diagnosis

  • Clinical Presentation: Fatigue, pallor, recurrent infections, bleeding manifestations 1.
  • Laboratory Findings: Cytopenias, dysplastic changes in bone marrow cells, peripheral blood smear abnormalities 1.
  • Bone Marrow Biopsy: Essential for diagnosis, showing dysplastic morphology and hypercellularity 1.
  • Genetic Testing: Chromosomal abnormalities and mutations (e.g., RUNX1, TP53) are crucial for risk stratification 1.
  • Flow Cytometry: To exclude other lymphoproliferative disorders 1.
  • Imaging: MRI or CT scans may be used to assess splenomegaly or other organ involvement 1.

    • Management

  • First-Line Treatment: Supportive care including transfusions, antibiotics, and hematopoietic growth factors 1.
  • Reactive Therapy: For symptomatic cytopenias or infections 1.
  • Chemotherapy: Specific regimens like low-dose cytarabine or decitabine in higher-risk cases 1.
  • Stem Cell Transplantation: Considered for younger patients with higher-risk MDS 1.
  • Interventional Radiology: Plays a role in managing complications such as thrombosis or vascular access issues 1.
  • Monitoring: Regular follow-up with bone marrow assessments to monitor disease progression 1.

    • Special Populations

  • Pediatric Considerations: Management requires specialized pediatric expertise, including interventional radiology services 1.
  • Comorbidities: Tailored supportive care and close monitoring are essential in patients with additional health issues 1.

    • Key Recommendations

  • Perform comprehensive bone marrow evaluation including morphology and genetic testing for accurate diagnosis and risk stratification (Evidence: Moderate 1).
  • Initiate supportive care measures promptly to manage cytopenias and infections (Evidence: Strong 1).
  • Consider stem cell transplantation in eligible pediatric patients with higher-risk MDS (Evidence: Moderate 1).

    • References

    1 Chippington SJ, Goodwin SJ. Interventional Radiology in Paediatrics. Current pediatric reviews 2015. link

    Original source

    1. [1]
      Interventional Radiology in Paediatrics. — Chippington SJ, Goodwin SJ Current pediatric reviews (2015)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG